Your browser doesn't support javascript.
loading
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer.
Lee, Sung Eun; Jang, Gun-Young; Lee, Ji Won; Park, Sang Hyeon; Han, Hee Dong; Park, Yeong-Min; Kang, Tae Heung.
Afiliação
  • Lee SE; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea.
  • Jang GY; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea.
  • Lee JW; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea.
  • Park SH; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea.
  • Han HD; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea.
  • Park YM; Department of Immunology, College of Medicine, Konkuk University, 268 Chungwon-daero, Chungju-si, Chungcheongbuk-do, 27478, South Korea. immun3023@kku.ac.kr.
  • Kang TH; Innovative Discovery Center, Prestigebiopharma Korea, Myeongjigukje 7-ro, 44, Gangseo-gu, Busan, South Korea. kangiron@kku.ac.kr.
Cancer Immunol Immunother ; 71(12): 3029-3042, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35610387
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article